• Corpus ID: 77300172

[Level of tear endothelin-1 and plasminogen in patients with glaucoma and proliferative diabetic retinopathy].

@article{Ta2013LevelOT,
  title={[Level of tear endothelin-1 and plasminogen in patients with glaucoma and proliferative diabetic retinopathy].},
  author={Pavlenko Ta and Chesnokova Nb and Davydova Hg and Okhotsimskaia Td and Beznos Ov and Grigor'ev Av},
  journal={Vestnik oftalmologii},
  year={2013},
  volume={129},
  pages={20}
}
A considerable tear endothelin-1 increase (2-3 times) has been found in patients with primary open-angle glaucoma and proliferative diabetic retinopathy. Patients with proliferative retinopathy also showed an increase of plasminogen level in tear fluid and a tendency of a similar increase in blood serum. No correlation between endothelin-1 and plasminogen levels in these pathologies was established. Tear endothelin-1 and plasminogen measurement could be used as an informative and non-invasive… 

Noninvasive diagnostic methods for diabetes mellitus from tear fluid

TLDR
Structural changes in tear fluid of patients with diabetes mellitus after insulin and oral antidiabetic drug treatment was compared with healthy subjects and the results of analysis, infrared spectroscopy and atomic force microscopy confirmed structural changes of patients in comparison with the tear fluids of healthy subjects.

Analysis of the Influence of Type of Diabetes Mellitus on the Development and Type of Glaucoma

TLDR
Patients with DM type have great chance of developing secondary glaucoma of the primary, especially in patients with diabetes mellitus type 2, which is more common in NPDR than in PDR.

Tear biomarkers for keratoconus

TLDR
The importance of tear fluid as a source of biomarker for keratoconus is discussed and how advances in technology have helped map the complexity of tears and thereby molecular readouts of the disease are mapped.

Molecular Biomarkers for Glaucoma

TLDR
Current and emerging molecular biomarkers candidates in glaucoma may eventually transition into clinical use and contribute to outline the concept of precision medicine and precision health in glAUcoma.

Genetic and Biochemical Biomarkers in Canine Glaucoma

TLDR
The genetic and biochemical markers associated with canine primary glaucoma include indicators of inflammation, oxidative stress, serum autoantibodies, matrix metalloproteinases, tumor necrosis factor–α, and transforming growth factor–β.

Unraveling the molecular repertoire of tears as a source of biomarkers: Beyond ocular diseases

TLDR
A discussion on the current state of biomarkers research in tears and their relevance for clinical practice is provided, the main results of clinical proteomics studies on systemic and eye diseases are reported, and recent advances in “omics” platforms for tears investigations are reported.